Medicine and Dentistry
DNA Binding
100%
Chronic Lymphocytic Leukemia
100%
Cancer Pathobiology
100%
Plant Extract
100%
Benzoic Acid
100%
DNA A
75%
Hematological Cancer
75%
Thalidomide
57%
Leukemia Cell
55%
Lentivirus Vector
40%
Fluorescence in Situ Hybridization
33%
IGHV@
33%
Bortezomib
28%
Cyclophosphamide
28%
Survival Estimate
28%
Predictive Marker
25%
Drug Resistance
25%
B-Cell Chronic Lymphocytic Leukemia
25%
Protein Kinase ZAP 70
25%
Protein Family
25%
Monoclonals
22%
Primary Tumor
20%
Lentivirus
20%
Signaling Molecule
16%
Parthenolide
16%
DNA B
16%
Bone Disease
14%
Caspase
12%
Survival Factor
12%
Patient Attendance
12%
Quarantine
12%
Caspase 8
12%
CD40 Ligand
12%
DNA Synthesis Inhibition
12%
First-in-Man Study
12%
Caspase 9
12%
Blocking Antibody
11%
Fibronectin
11%
Nonsteroid Antiinflammatory Agent
11%
Transcription Factor Rel
11%
Natalizumab
11%
Chemokine Receptor CXCR4
11%
Immunophenotyping
11%
Fludarabine
11%
Gene Mutation
11%
Vasculotropin Receptor
11%
Protein Mcl 1
11%
Drug Action
11%
Protein Analysis
11%
Immunoglobulin Gene
8%
Pharmacology, Toxicology and Pharmaceutical Science
Fludarabine
100%
Benzoic Acid
100%
Chronic Lymphatic Leukemia
82%
Imine
66%
Bisulfite
66%
Phase II Trials
66%
Antitumor Activity
66%
Thalidomide
57%
Protein Kinase ZAP 70
50%
Irinotecan
33%
Antineoplastic Antibiotic
33%
Carbon 11
33%
Erosion
30%
Cell Cycle Checkpoint
28%
Cyclophosphamide
28%
Bortezomib
28%
DNA A
25%
Disease Exacerbation
18%
Bone Disease
14%
Sepsis
14%
Hypercalcemia
14%
Caspase 8
12%
Overall Survival
12%
Survival Factor
12%
Caspase 9
12%
CD40 Ligand
12%
Transcription Factor Rel
11%
Cell Division
9%
Protein P53
9%
Diseases
9%
Deuterium Oxide
7%
Biochemistry, Genetics and Molecular Biology
Telomere
100%
Sodium Bisulfite
66%
Antineoplastic Activity
66%
Single Drug Dose
66%
Telomere Length
37%
Crosslinking of DNA
33%
Drug Dose Regimen
33%
Recombination Repair
33%
ERCC1
33%
GI50
33%
IGHV@
33%
Fluorescence in Situ Hybridization
33%
CD38
33%
Cyclophosphamide
28%
ZAP70
25%
Survival
25%
Telomerase
16%
Hypercalcaemia
14%
Long Term Survival
14%
Cell Division
14%
Mutation
12%
High Risk Population
12%
Multivariate Analysis
12%
Aptitude
12%
Overall Survival
12%
Comparative Genomic Hybridization
9%
Protein Sequencing
9%
Immunoglobulin Gene
8%
Cytogenetics
8%
Clonal Evolution
7%
CD5
7%
Loss of Heterozygosity
7%
CD23
7%
Telomere Shortening
7%